Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7078409 Fused quinazoline derivatives useful as tyrosine kinase inhibitors

Patent 7078409 was granted and assigned to Beta Pharma, Inc. on July, 2006 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Beta Pharma, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

70784090

Patent Inventor Names

Hang Chen0

Charles Davis0

Don Zhang0

Guojian Xie0

Mehrnaz Kamal0

Yinxiang Wang0

Zhengzhuang Cheng0

Date of Patent

July 18, 2006

Patent Application Number

103976600

Date Filed

March 26, 2003

Patent Citations Received

‌

US Patent 12103937 Substituted pyridines and pyridazines as TYK2 inhibitors

‌

US Patent 12084458 Substituted pyridines, pyridazines, and pyrimidines as TYK2 inhibitors

‌

US Patent 12122785 Substituted pyridines, pyridazines, pyrimidines, and 1,2,4-triazines as TYK2 inhibitors

Patent Primary Examiner

‌

James O. Wilson

Patent abstract

The present invention is directed to a compound having the structure

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7078409 Fused quinazoline derivatives useful as tyrosine kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API